Since meprin β expression is upregulated in AD patients’ brains [28–30], we aimed to generate a meprin β knock-in mouse conditionally overexpressing meprin β in the brain to achieve pathological expression levels of meprin β. The gene discussed is MEP1B; the disease is Alzheimer disease.